Bridgebio Oncology Therapeutics, Inc. · NASDAQ:BBOT
Ben Yong had 1,047 Bridgebio Oncology Therapeutics, Inc. shares withheld for tax (Form 4)
Traded Apr 1, 2026 · Filed May 5, 2026
On Apr 1, 2026, Ben Yong (Chief Med & Dev Officer) had 1,047 Bridgebio Oncology Therapeutics, Inc. shares withheld for tax at US$9.03 for US$9,454, leaving 45,623 shares. Filed May 5, 2026 (Form 4).
- Withheld for tax
- 1,047 shares
- Price
- US$9.03
- Value
- US$9,454
- Holding after
- 45,623 shares
- Trading plan
- No
- Role
- Chief Med & Dev Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | Shares withheld for tax | 1,047 | US$9.03 | 45,623 | Direct |
Source
Related
- Bridgebio Oncology Therapeutics, Inc.
- Ben Yong
- Bridgebio Oncology Therapeutics, Inc. shareholders
- Form 4 · Ben Yong · Oct 5, 2026
- Form 4 · Ben Yong · Jul 6, 2026
- Form 4 · Beltran Pedro · Oct 5, 2026
- Form 4 · Elmelech Idan · Oct 5, 2026
- Form 4 · Cobo Marc · Oct 5, 2026
- Form 4 · Cobo Marc · Sep 14, 2026
- Form 4 · Cobo Marc · Jul 6, 2026